6
Oct
2026
Taiwan Pharma Pavilion
About Taiwan Pharma Pavilion
Certifications
Categories
-
Country/Region:Taiwan
-
On CPHI since:2025
-
Certificates:2
-
Employees:1000 - 4999
Company types
Primary activities
Taiwan Pharma Pavilion Resources (2)
-
Brochure GlycoNex: Anti-Glycan ADC & Biosimilar Partnering
Clinical-stage anti-glycan ADC GNX1021 (Ph1) and registration-ready denosumab biosimilar SPD8. Seeking licensing and co-development partners. -
Brochure Taiwan Pharma Pavilion 2026 – Delegation Profile
Meet 22 Taiwanese pharmaceutical and biotech companies seeking global partners in licensing, CDMO, APIs, biologics, drug delivery and CRO services.